Incidence of contrast-induced nephropathy in hospitalised patients with cancer

European Radiology

Volumn 24, Issue 1, 2014, Pages 184-190

  Cicin, Irfan ^a   Erdogan, Bulent ^a   Gulsen, Emrah ^a   Uzunoglu, Sernaz ^a   Sut, Necdet ^a   Turkmen, Esma ^a   Kodaz, Hilmi ^a   Ustundag, Sedat ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Bevacizumab; Cancer; Chemotherapy; Contrast induced nephropathy

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CREATININE; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IOHEXOL; IOPROMIDE; IRINOTECAN; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; CONTRAST MEDIA; FEMALE; HUMANS; INCIDENCE; INPATIENTS; IOHEXOL; KIDNEY DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TURKEY;

EID: 84890411322     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2996-6     Document Type: Article

References (26)

1. Detrenis S, Meschi M, Musini S et al (2005) Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art. Nephrol Dial Transplant 20:1542-1550
2. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39:930-936
3. Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259-2264
4. McCullough PA, Wolyn R, Rocher LL et al (1997) Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:68-75
5. Morcos SK, Thomsen HS, Webb JAW (1999) Contrast-media-induced nephrotoxicity: A consensus report. Contrast media safety committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602-1613
6. Manske CL, Sprafka JM, Strony JT, Wang Y (1990) Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620
7. Morcos SK (1998) Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71:357-365
8. Katzberg RW (1997) Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 204:297-312
9. Barrett BJ, Parfrey PS (1994) Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 331:1449-1450
10. Kolonko A, Wiecek A (1998) Contrast-associated nephropathy: Old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant 13:803-806
11. Cheruvu B, Henning K, Mulligan J et al (2007) Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. J Comput Assist Tomogr 31:493-498
12. Arakawa K, Suzuki H, NaitohMet al (1996) Role of adenosine in the renal responses to contrast medium. Kidney Int 49:1199-1206
13. Workman RJ, ShaffMI, Jackson RVet al (1993) Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin systemand renal prostacyclin in the dog. Invest Radiol 18:160-166
14. Seeliger E, Flemming B,Wronski Tet al (2007) Viscosity of contrast media perturbs renal hemodynamics. J Am Soc Nephrol 18:2912-2920
15. Gill RW (1987) Doppler ultrasound: Physics aspects. Semin Perinatol 11:292-299
16. Murphy SW, Barrett BJ, Parfrey PS (2000) Contrast nephropathy. J Am Soc Nephrol 11:177-182
17. Lancelot E, Idée JM, Couturier Vet al (1999) Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: A potential cause of nephrotoxicity. J Appl Toxicol 19:341-346
18. Grabowski EF, Jang IK, Gold H et al (1996) Variability of platelet degranulation by different contrast media. Acad Radiol 3(Suppl 3): 485-487
19. Soultati A, Mountzios G, Avgerinou C et al (2012) Papadimitriou C Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications. Cancer Treat Rev 38: 473-483
20. Heyman SN, Reichman J, Brezis M (1999) Pathophysiology of radiocontrast nephropathy. A role for medullary hypoxia. Invest Radiol 34:685-691
21. Baliga R, Ueda N,Walker PD, Shah SV (1997) Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 29:465-477
22. Moreau JF, Droz D, Sabto J et al (1975) Osmotic nephrosis induced by water-soluble triiodinated contrast media in man, a retrospective study of 47 cases. Radiology 115:329-336
23. Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542-1548
24. Dangas G, Iakovou I, Nikolsky E et al (2005) Contrast induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95:13-19
25. Thomson Micromedex Healthcare Series, vol 121 (expired 10/31/04). Thomson Micromedex, Greenwood Village
26. Ronco C, Stacul F, McCullough PA (2013) Subclinical acute kidney injury (AKI) due to iodine-based contrast media. Eur Radiol 23:319-323